©The Author(s) 2025.
World J Hepatol. Sep 27, 2025; 17(9): 109179
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.109179
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.109179
Table 1 Baseline characteristics of the study participants, n (%)/mean ± SD/median (interquartile range)
| Characteristic, n = 153 | Finding |
| Male | 123 (80.4) |
| Age (years) | 56.3 ± 10.9 |
| AST (U/L) | 93.2 (49.4-149.5) |
| ALT (U/L) | 48.0 (30.2-82.9) |
| Total bilirubin (μmol/L) | 41.8 (20.7-69.8) |
| Albumin (g/L) | 27.1 (22.0-33.1) |
| Hemoglobin (g/L) | 111.0 (94.0-124.0) |
| Platelet as × 109/L | 94.0 (59.0-145.0) |
| AFP (ng/Ml) | 4.66 (2.4-13.0) |
| Child-Pugh | |
| A | 22 (14.4) |
| B | 64 (41.8) |
| C | 67 (43.8) |
| M2BPGi C.O.I. | 7.1 ± 3.7 |
| FibroScan in kPa, n = 77 | 36.4 ± 20.5 |
- Citation: Doan TH, Nguyen KM, Nguyen XV, Pham ATN, Le ND. Evaluating thresholds of Mac-2 binding protein glycosylation isomer in association with clinical outcomes in patients with cirrhosis. World J Hepatol 2025; 17(9): 109179
- URL: https://www.wjgnet.com/1948-5182/full/v17/i9/109179.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i9.109179